Search Results 61-70 of 16064 for CLL

  1. Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis - Mayo Clinic

    Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell ...

  2. Pirtobrutinib (oral route) - Mayo Clinic

    For mantle cell lymphoma, chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL):. Adults—200 milligrams (mg) once a day. Your doctor may ...

  3. Living With Cancer: Chronic lymphocytic leukemia - Mayo Clinic News Network

    Chronic lymphocytic leukemia is a type of cancer of the blood and bone marrow that most commonly affects older adults. Learn about causes, symptoms and ...

  4. Mayo Clinic-Led Researchers Confirm Gene Variants Associated With The Most Common Adult Leukemia

    A national team of researchers led by Mayo Clinic has found that patients with chronic lymphocytic leukemia (CLL) are more likely to have similar DNA ...

  5. A Study to Define Axl Expression Level in Skin Biopsy Specimens from Patients with Skin Cancer in Relation to Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to define the presence and role of Axl in the risk of skin cancers in patients with CLL as well as non-CLL patients.

  6. A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia - Mayo Clinic

    Diagnosis of Chronic Lymphocytic Leukemia (B-CLL). Exclusion Criteria: Pregnant. Participating Mayo Clinic locations. Study statuses change often. Please ...

  7. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

    About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...

  8. Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL) with 17p deletion. An increased rate of deaths and serious adverse events (SAEs) among participants with front-line CLL ...

  9. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Publications - Curtis A. Hanson, M.D. - Mayo Clinic

    Chronic lymphocytic leukemia (CLL) with Reed-Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter? Blood ...